A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
Condition(s):Hereditary AngioedemaLast Updated:December 8, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Hereditary AngioedemaLast Updated:December 8, 2017Completed
Condition(s):Hereditary Angioedema; Angioneurotic Edema; Genetic DisordersLast Updated:October 2, 2012Completed
Condition(s):Acute Kidney InjuryLast Updated:August 8, 2018Completed
Condition(s):Genetic DisordersLast Updated:February 22, 2013Completed
Condition(s):Genetic DisordersLast Updated:April 25, 2013Completed
Condition(s):Genetic Disorders; Hereditary AngioedemaLast Updated:June 26, 2018Completed
Condition(s):CVI – Common Variable ImmunodeficiencyLast Updated:February 15, 2021Completed
Condition(s):Hereditary AngioedemaLast Updated:August 7, 2015Completed
Condition(s):Graft Rejection; Kidney TransplantationLast Updated:February 17, 2012Withdrawn
Condition(s):Hereditary AngioedemaLast Updated:February 4, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.